Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Padiatr Oncol. 2016;37:278–85.
2. Bruni L, Albero G, Serrano B, Mena M, Gomez D, Munoz J, et al. ICO information center on HPV & Cancer (HPV information center). Human papilloma viruses and related diseases in the world. Summary report 27 July 2017. Last accessed 29th April 2019. Available from http://www.hpvcenter.net.
3. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of “tumor escape” phenotypes. Nat immunol. 2002;3:999–1005.
4. Zehbe I, Hohn H, Pilch H, Neukirch C, Freitag K, Maeurer MJ. Differential MHC class II component expression in HPV-possitive cervical cancer cells:implication for immune surveillance. Int J Cancer. 2005;117:807–15.
5. Bhatla N, Berek JS, Fredes MC, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019;145:129–35.